NanoViricides
NNVC
#10528
Rank
โ‚น3.45 B
Marketcap
โ‚น135.34
Share price
5.93%
Change (1 day)
-24.86%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2026 (TTM): -โ‚น39.14

According to NanoViricides's latest financial reports the company's current EPS (TTM) is -โ‚น41.64. In 2025 the company made an earnings per share (EPS) of -โ‚น59.62 an increase over its 2024 EPS that were of -โ‚น66.25.

EPS history for NanoViricides from 2005 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น39.14-34.36%
2025-โ‚น59.62-10%
2024-โ‚น66.25-5.41%
2023-โ‚น70.035.71%
2022-โ‚น66.25-13.58%
2021-โ‚น76.66-66.11%
2020-โ‚น226.191.7%
2019-โ‚น222.40-10.98%
2018-โ‚น249.85-22.35%
2017-โ‚น321.78-10.53%
2016-โ‚น359.63375%
2015-โ‚น75.71-85.19%
2014-โ‚น511.0642.11%
2013-โ‚น359.6326.67%
2012-โ‚น283.92-6.25%
2011-โ‚น302.8514.28%
2010-โ‚น264.99100%
2009-โ‚น132.50-0%
2008-โ‚น132.50-33.33%
2007-โ‚น198.74-0%
2006-โ‚น198.744445.07%
2005-โ‚น4.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
-โ‚น246.06 490.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น119.77-387.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น429.67-1,131.82%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น302.63-826.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-โ‚น143.85 245.45%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚น136.28 227.27%๐Ÿ‡บ๐Ÿ‡ธ USA